Learning Objectives:

    1. Review the historical events and findings that have contributed to our modern understanding of antibody-mediated encephalitis.
    2. Identify the clinical findings and test results that distinguish patients with antibody-mediated encephalitis in clinical practice.
    3. Apply understanding of antibody-mediated encephalitis to facilitate early recognition and improve treatment of affected patients.
Session date: 
Thursday, May 20, 2021 - 7:30am to 8:30am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Gregory S. Day, MD, MSc